Document:

Document

Exhibit 10.26

BELLICUM PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”)
dated as of November 3, 2021, is entered into by and between Bellicum Pharmaceuticals, Inc. a Delaware corporation, having a location at 3730 Kirby Drive, Suite 1200, Houston, Texas 77098 (the “Company”) and Charity Scripture, MS, PharmD, BCOP. (the “Executive”).

WHEREAS, Company and Executive are Parties to that certain Employment Agreement dated June 19, 2020 as amended on September 14, 2020 and January 1, 2021 (the “Original Employment Agreement”);

WHEREAS, the Company wishes to continue employing Executive in a new full-time role as Chief Development Officer and to provide Executive with certain compensation and benefits in return for Executive’s services, and Executive agrees to be employed by the Company in such capacity and to receive the compensation and benefits on the terms and conditions set forth herein;

WHEREAS, the Company and Executive desire to enter into this Agreement to become effective, subject to Executive’s signature below as of December 1, 2021 (the “Effective Date”) in order to memorialize the revised terms and conditions of Executive’s employment by the Company; and

WHEREAS, Executive’s agreement to and compliance with the provisions in Sections 9 through 11 of this Agreement are a material factor, material inducement and material condition to the Company’s entering into this Agreement.

NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the parties agree that the above-described Original Employment Agreement shall hereby be amended and restated in its entirety as follows:

1.At-Will Employment. The Company and Executive acknowledge that either Party has the right to terminate Executive’s employment with the Company at any time for any reason whatsoever, with or without cause, subject to the provisions of Section 6 and 7 herein. This at-will employment relationship cannot be changed except in a writing signed by both Executive and the Board of Directors of the Company (or a duly authorized committee thereof, if applicable) (the “Board”). Any rights of Executive to additional payments or other benefits from the Company upon any such termination of employment shall be governed by Section 7 of this Agreement.

2.Position and Location. Executive’s duties under this Agreement shall be to serve on a full-time basis as Chief Development Officer with the responsibilities, rights, authority and duties pertaining to such office as are established from time to time by the Company’s Chief Executive Officer (“CEO”), and Executive shall report to the CEO. Executive shall also act as an officer and/or director and/or manager of such Affiliates of the Company as may be designated by the CEO from time to time, commensurate with Executive’s office, all without further compensation, other than as provided in this Agreement. As used herein, “Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with, the

Company. Executive’s principal place of business for performance of services to the Company under this Agreement shall be in the San Francisco Bay area. The Company will, from time to time, reasonably require Executive to travel temporarily to other locations, including to the Company’s headquarters in Houston, Texas in connection with the Company’s business.

3.Commitment. Executive will devote substantially all of her business time and best efforts to the performance of her duties hereunder; provided, however, that Executive shall be allowed, to the extent that such activities do not interfere in any material respect with the performance of her duties and responsibilities hereunder and do not conflict with the financial, fiduciary or other interests of the Company (or its Affiliates), as determined in the sole discretion of the CEO, to manage her passive personal investments and to serve on corporate, civic, charitable and industry boards or committees. Notwithstanding the foregoing, Executive agrees that she shall only serve on for-profit boards of directors or for-profit advisory committees if such service is approved in advance in the sole discretion of the CEO.

4.Compensation.

(a)Base Salary. During Executive’s employment with the Company, the Company shall pay Executive a base salary at the annual rate of $400,000, less payroll deductions and withholdings, which shall be payable in accordance with the standard payroll practices of the Company. Executive’s base salary shall be subject to periodic review and adjustment by the Board from time to time in the discretion of the Board.

(b)Performance Bonus. For the applicable period covered by the Company’s bonus plan then in effect (currently either on a quarterly or an annual basis) as determined by the Board in its sole discretion (the “Bonus Period”), Executive shall be eligible to receive a performance bonus (“Performance Bonus”) from the Company, based on a target annual bonus equal to forty percent (40%) of Executive’s base salary. The Performance Bonus will be based on achievement of individual and/or Company goals established by the Board in its sole discretion in advance of each Bonus Period. Following the close of each Bonus Period, the Board will determine whether Executive has earned a Performance Bonus, and the amount of any such bonus. Payment of the Performance Bonus shall be expressly conditioned upon Executive’s employment with the Company on the date that the Performance Bonus is paid, except as provided in Section 7(b)(iv) and Section 7(c) below. The Performance Bonus shall be paid within ninety (90) days after the end of the Bonus Period for which it relates. Executive’s target Performance Bonus will be subject to periodic review and adjustment by the Board from time to time.

(c)Reimbursement of Expenses.

(i)The Company shall reimburse Executive for reasonable travel and other business expenses incurred by Executive in the performance of her duties hereunder, in accordance with the Company’s policies as in effect from time to time.

(ii)Any reimbursements will be paid to Executive within thirty (30) days after the date Executive submits receipts for the expenses, provided Executive submits those receipts within forty-five (45) days after Executive incurs the expense. For the avoidance of doubt, to the extent that any reimbursements payable to Executive are subject to the provisions of Section 409A (as defined in Section 14 below): (i) to be eligible to obtain reimbursement for such expenses

			
	2

Executive must submit expense reports within forty-five (45) days after the expense is incurred,
(ii) any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, (iii) the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year, and (iv) the right to reimbursement under this agreement will not be subject to liquidation or exchange for another benefit.

5.Benefits. Subject to applicable eligibility requirements, Executive shall be entitled to participate in all benefit plans and arrangements and fringe benefits and programs that may be provided to senior executives of the Company from time to time, subject to plan terms and generally applicable Company policies. Executive is entitled to participate in personal time off and holiday benefits in accordance with Company policy from time to time for its senior executives.

6.Termination.

(a)Termination. The employment of Executive under this Agreement shall terminate upon the earliest to occur of any of the following events:

(i)the death of Executive;

(ii)the termination of Executive’s employment by the Company due to Executive’s Disability pursuant to Section 6(b) hereof;

(iii)the termination of Executive’s employment by Executive for any reason;

(iv)the termination of Executive’s employment by the Company without Cause;

(v)the termination of Executive’s employment by the Company for Cause pursuant to Section 6(c) after providing the Notice of Termination for Cause pursuant to Section 6(d); or

(vi)the termination of Executive’s employment upon mutual agreement in writing between the Company and Executive.

(b)Disability. For purposes of this Agreement, “Disability” means that Executive has been unable, for ninety (90) consecutive days, or for periods aggregating one hundred and twenty
(120) business days in any period of twelve consecutive months, to perform Executive’s duties under this Agreement, as a result of physical or mental impairment, illness or injury, as determined in good faith by the Board. A termination of Executive’s employment for Disability shall be communicated to Executive by written notice and shall be effective on the 10th day after sending such notice to Executive (the “Disability Effective Date”), unless Executive returns to performance of Executive’s duties before the Disability Effective Date.

(c)Cause. For purposes of this Agreement, the term “Cause” shall mean (i) Executive’s willful misconduct which is demonstrably and materially injurious to the Company’s reputation, financial condition, or business relationships; (ii) the failure of Executive to attempt in good faith to follow the legal written direction of the CEO or the Board; (iii) the failure by Executive to attempt in good faith to perform the duties required of her hereunder (other than any

			
	3

such failure resulting from incapacity due to physical or mental illness) after a written demand for substantial performance is delivered to Executive by the CEO which specifically identifies the manner in which it is believed that Executive has failed to attempt to perform her duties hereunder;
(iv) Executive being convicted of, indicted for, or pleading guilty or nolo contendere to, a felony or any crime involving dishonesty, fraud or moral turpitude; (v) Executive’s dishonesty with regard to the Company or in the performance of her duties hereunder, which in either case has a material adverse effect on the Company; (vi) Executive’s material breach of this Agreement unless corrected by Executive within ten (10) days of the Company’s written notification to Executive of such breach; or, (vii) Executive’s failure to comply in any material respect with the Company’s policies and/or procedures, unless corrected by Executive within ten (10) days of the Company’s written notification to Executive of such breach.

(d)Notice of Termination for Cause. Notice of Termination for Cause shall mean a notice to Executive that shall indicate the specific termination provision in Section 6(c) relied upon and shall set forth in reasonable detail the facts and circumstances which provide a basis for Termination for Cause.

7.Consequences of Termination of Employment.

(a)General. If Executive’s employment is terminated for any reason or no reason, the Company shall pay to Executive or to Executive’s legal representatives, if applicable: (i) any base salary earned, but unpaid; and, (ii) any unreimbursed business expenses payable pursuant to Section 4 hereof and any accrued but unused personal time off benefits and any other payments or benefits required by applicable law (collectively “Accrued Amounts”), which amounts shall be promptly paid in a lump sum to Executive, or in the case of Executive’s death to Executive’s estate. Other than the Accrued Amounts, Executive or Executive’s legal representatives shall not be entitled to any additional compensation or benefits if Executive’s employment is terminated for any reason other than by reason of Executive’s Involuntary Termination (as defined in Section 7(b) below). If Executive’s employment terminates due to an Involuntary Termination, Executive will be eligible to receive the additional compensation and benefits described in Section 7(b) and 7(c), as applicable.

(b)Involuntary Termination. If Executive’s employment with the Company is terminated by the Company without Cause (and other than as a result of Executive’s death or Disability) and provided in any case such termination constitutes a “separation from service”, as defined under Treasury Regulation Section 1.409A-1(h)) (a “Separation from Service”) (such termination an “Involuntary Termination”), in addition to the Accrued Amounts, Executive shall be entitled to receive the severance benefits described below in this Section 7(b), subject in all events to Executive’s compliance with Section 7(d) below:

(i)Executive shall receive continued payment of Executive’s Base Salary (as defined below) for the first twelve (12) months after the date of such termination (the “Severance Period”), paid over the Company’s regular payroll schedule;

(ii)Executive shall receive a lump sum amount equal Executive’s target Performance Bonus for the applicable Bonus Period in which such termination occurs, pro-rated based on the ratio that the number of days from the beginning of such Bonus Period in which such termination occurs through the date of termination bears to the total number of calendar days

			
	4

in the Bonus Period (the “Bonus Payment”);
(c)Involuntary Termination in Connection with a Change in Control. In the event that Executive’s Involuntary Termination occurs immediately prior to, on or within the twelve (12) months following the consummation of a Change in Control (as defined below) and subject in all events to Executive’s compliance with Section 7(d) below, then Executive shall be entitled to the benefits provided above in Section 7(b), except that:

(i)the Bonus Payment shall equal the Executive’s full target Performance Bonus for one calendar year rather than a pro-rated target bonus; and

(ii)the vesting of all of Executive’s outstanding stock options and other equity awards that are subject to time-based vesting requirements shall accelerate in full such that all such equity awards shall be deemed fully vested as of the date of Executive’s Involuntary Termination.

For the avoidance of doubt, in no event shall Executive be entitled to benefits under both Section 7(b) and this Section 7(c). If Executive is eligible for benefits under both Section 7(b) and this Section 7(c), Executive shall receive the benefits set forth in this Section 7(c) and such benefits will be reduced by any benefits previously provided to Executive under Section 7(b).

(d)Conditions and Timing for Severance Benefits. The severance benefits set forth in Section 7(b) and Section 7(c) above are expressly conditioned upon: (i) Executive continuing to comply with Executive’s obligations under this Agreement, including Sections 8 through 11; and
(ii) Executive signing and not revoking a general release of legal claims in a form provided by the Company (the “Release”) within the applicable deadline set forth therein and permitting the Release to become effective in accordance with its terms, which must occur no later than the Release Deadline (as defined in Section 14 below). The salary continuation payments described in Sections 7(b) will be paid in substantially equal installments on the Company’s regular payroll schedule and subject to standard deductions and withholdings over the Severance Period following termination; provided, however, that no payments will be made prior to the effectiveness of the Release. On the effective date of the Release, the Company will pay Executive the salary continuation payments that Executive would have received on or prior to such date in a lump sum under the original schedule but for the delay while waiting for the effectiveness of the Release, with the balance of the payments being paid as originally scheduled. Bonus Payments described in Section 7(b) and 7(c) will be paid in a lump sum cash payment on the first regular payroll date of the Company following the effective date of the Release, but in no event later than March 15 of the year following the year in which Executive’s termination of employment occurred. All severance benefits described in this Section 7 will be subject to all applicable standard required deductions and withholdings.

(e)Definitions.

(i)“Base Salary” means Executive’s annual base salary in effect immediately prior to Executive’s termination.
			
	5

(i)“Change in Control” means a “Change in Control” as defined in the Company’s 2019 Equity Incentive Plan.

8.Confidential Information. “Confidential Information” as used in this Agreement, includes but is not limited to, specialized training received by Executive; products already developed or that will be developed by the Company, including but not limited to, products in the field of cancer immunotherapy, including metastatic castrate resistant prostate cancer and graft versus host disease; research and development materials related to the manipulation of dendritic cell signaling pathways to enhance the immune response; research and development materials, electronic databases; computer programs and technologies; marketing and/or scientific studies and analysis; product and pricing knowledge; manufacturing methods; supplier lists and information; any and all information concerning past, present and future customers, referral sources or vendors; contracts and licenses; management structure, company ownership, personnel information (including the performance, skills, abilities and payment of employees); purchasing, accounting and business systems; short and long range business planning; data regarding the Company’s past, current and future financial performance, sales performance, and current and/or future plans to increase the Company’s market share by targeting specific medical issues, demographic and/or geographic markets; standard operating procedures; financial information; trade secrets, copyrights, derivative works, patents, inventions, know-how, and other intellectual property; business policies; submissions to government or regulatory agencies and related information; methods of operation; implementation strategies; promotional information and techniques; marketing presentations; price lists; files or other information; pricing strategies; computer files; samples; customer originals; or any other confidential information concerning the business and affairs of the Company. The Company’s Confidential Information is also comprised of the personal information received from third parties and/or confidential and proprietary information regarding research, products, or clinical trials received from third parties, but only if such confidential information is reduced to writing and marked “Confidential” by the third party. All such confidential information obtained by Executive, whether in writing, any other tangible form of expression or disclosed orally or through visual means or otherwise, and regardless of whether such information bears a confidential or proprietary legend, will be presumed to be Confidential Information. Executive acknowledges that the Confidential Information is vital, valuable, sensitive, confidential and proprietary to Company and provides Company with a competitive advantage. Executive further acknowledges that Company’s Confidential Information is dynamic, and constantly changes in nature and/or quantity, given that Company continues to refine its Confidential Information. The obligations specified in this Section 8 shall not apply, and Executive shall have no further obligations under this Agreement with respect to any Confidential Information that: a) is available to the public at the time of disclosure to Executive or becomes publicly known through no breach of the undertakings hereunder by Executive or to the knowledge of Executive, any third party; b) becomes known to Executive through disclosure by sources other than the Company and its Affiliates and in the course of Executive’s service to the Company, said sources being under no obligation of confidentiality to the Company with respect to such Confidential Information; c) is approved by the Company for release; or d) has been independently developed by Executive without benefit of the Confidential Information and on Executive’s own time and without use of Company resources. Executive understands and agrees that the Company may require her, as a condition to continued employment, to execute and abide by the terms of a standard proprietary information and inventions agreement with the Company which will further set forth the terms of, and prohibit the unauthorized use or disclosure of, the Company’s

			
	6

confidential and proprietary information (the “PIIA”) and that such PIIA shall become part of this Agreement and Executive’s obligations under this Agreement.

9.Non-Solicitation, Etc.

(a)Company Promises.

(i)This Agreement is entered into pursuant to Executive’s agreement to these non-solicitation provisions. Executive’s agreement to the provisions in Sections 9 through 11 is a material condition of the Company’s entering into this Agreement and continued employment of Executive.

(b)Executive’s Promises. In exchange for the Company’s promises listed above and all other consideration provided pursuant to this Agreement, to which these promises are ancillary, Executive promises as follows:

(i)Executive will not, during or after Executive’s employment with the Company, use, copy, remove, disclose or disseminate to any person or entity, the Company’s Confidential Information, except (i) as required in the course of performing Executive’s duties with the Company, for the benefit of the Company, or (ii) when required to do so by a court of law, by any governmental agency having supervisory authority over the business of the Company or by any administrative or legislative body (including a committee thereof) with apparent jurisdiction to order Executive to divulge, disclose or make accessible such information, it being understood that Executive will promptly notify the Company of such requirement so that the Company may seek to obtain a protective order.

(ii)Following employment termination, Executive will immediately return to the Company all materials created, received or utilized in any way in conjunction with Executive’s work performed with the Company that in any way incorporates, reflects or constitutes Company’s Confidential Information.

(iii)Executive acknowledges that the market for the Company’s products, services, and activities is global, and that the products, services and/or activities can be provided anywhere in the world. Executive recognizes that the Company draws its customers and/or clients from around the world because it will seek to file patents and run clinical trials in countries around the world and sell its product to consumers around the world and/or pharmaceutical companies located around the world. Moreover, Executive recognizes that the Company’s customers may be contacted by telephone, in person, or in writing (including e-mail via the Internet). Executive further acknowledges that due to the international scope of the Company’s customer and client base, the following non-solicitation restriction is necessary.

(iv)Executive agrees and acknowledges that Company will not be provided access to Confidential Information, as defined in Section 8, from or belonging to a third party that Executive was exposed to or received from said third party prior to the execution date of this Agreement and that is the subject of any confidentiality requirement of any kind between Executive and said third party. EXECUTIVE ALSO AGREES TO INDEMNIFY, REIMBURSE, AND HOLD HARMLESS THE COMPANY FOR ALL ATTORNEY FEES, EXPENSES, COSTS, HARM, OR RELATED COSTS TO COMPANY ARISING FROM

			
	7

OR AS A RESULT OF ANY ACTUAL CAUSE OF ACTION OR CLAIM BROUGHT AGAINST COMPANY OR EXECUTIVE RELATED TO ANY ACTUAL BREACH OF
THIS SECTION BY EXECUTIVE. Company agrees that: (A) Executive shall be allowed to participate fully in the defense of any such action against Company and in any settlement negotiations, and (B) any payment to Company by Executive under this Section shall be only after any settlement has been consummated or judicial action has become final and non-appealable.

(c)Non-Solicitation of Employees. Executive agrees that during her employment and for twelve (12) months following termination of her employment, Executive will not, directly or indirectly, (i) induce or solicit any person who was an employee, consultant or independent contractor of the Company or any of its Affiliates, to terminate such individual’s employment or service with the Company or any of its Affiliates or (ii) assist any other person or entity in such activities.

(d)Extension of Non-Solicitation and Non-Recruitment Periods. If Executive is found by a court of competent jurisdiction to have breached any promise made in Section 9 of this Agreement, the period specified in Section 9(c) of this Agreement shall be extended by one month for every month in which Executive was in breach so that the Company has the full benefit of the time period provided in Section 9(c).

10.Injunction. Executive recognizes that Executive’s services hereunder are of a special, unique, unusual, extraordinary and intellectual character giving them a peculiar value, the loss of which cannot be reasonably or adequately compensated for in damages. Executive acknowledges that if Executive were to leave the employ of the Company for any reason and compete, directly or indirectly, with the Company, or solicit the Company’s employees, or use or disclose, directly or indirectly, the Company’s Confidential Information (whether in tangible form or memorized), that such competition, solicitation, use and/or disclosure would cause the Company irreparable harm and injury for which no adequate remedy at law exists. Executive agrees this Agreement is the narrowest way to protect the Company’s interests. Therefore, in the event of the breach or threatened breach of the provisions of this Agreement by Executive, the Company shall be entitled to obtain injunctive relief to enjoin such breach or threatened breach, in addition to all other remedies and alternatives that may be available at law or in equity. Executive acknowledges that the remedies contained in this Agreement for violation of this Agreement are not the exclusive remedies that the Company may pursue.

11.Inventions.

(a)Inventions Retained and Licensed. Executive has attached hereto as Exhibit A, a list describing all inventions, original works of authorship, derivative works, developments, improvements and trade secrets that (i) were made by Executive prior to her employment with the Company, (ii) belong to Executive, (iii) relate to the Company’s proposed business, products or research and development and (iv) are not assigned to the Company hereunder (collectively, “Prior Inventions”); or, if no such list is attached, Executive represents that there are no such Prior Inventions. Executive agrees that Executive will not incorporate, or permit to be incorporated, any Prior Invention owned by Executive or in which Executive has an interest into a Company product, process or service without the Company’s prior written consent. Nevertheless, if, in the course of Executive’s employment with the Company, Executive

			
	8

incorporates into a Company product, process or service a Prior Invention owned by Executive or in which Executive has an interest, Executive hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, transferable, sublicensable, worldwide license to reproduce, make derivative works of, distribute, perform, display, import, make, have made, modify, use, sell, offer to sell, and exploit in any other way such Prior Invention as part of or in connection with such product, process or service, and to practice any method related thereto.

(b)Assignment of Inventions. Executive agrees that Executive will promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all Executive’s right, title, and interest in and to any and all inventions, original works of authorship, derivative works, developments, concepts, modifications, improvements (including improvements to Confidential Information), designs, discoveries, ideas, know-how, trademarks, trade dress, trade secrets or other intellectual property, whether or not patentable or registrable under copyright or similar laws, which Executive may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, whether or not reduced to drawings, written descriptions, documentation or other tangible form, as applicable, during the period of time Executive is employed by the Company (collectively, “Inventions”), except as provided in Section 11(f) below. Executive further acknowledges that all original works of authorship which are made by Executive (solely or jointly with others) within the scope of and during the period of Executive’s employment with the Company and which are protectable by copyright are “works made for hire” as that term is defined in the United States Copyright Act. Executive understands and agrees that the decision whether or not to commercialize or market any Invention is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty will be due to Executive as a result of the Company’s efforts to commercialize or market any such Invention.

(c)Inventions Assigned to the United States. Executive agrees to assign to the United States government all Executive’s right, title, and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its agencies.

(d)Maintenance of Records. Executive agrees to keep and maintain adequate and current written records of all Inventions during the term of Executive’s employment with the Company. The records will be in the form of notes, sketches, drawings and any other format that may be specified by the Board. The records will be available to and remain the Company’s sole property at all times.

(e)Patent and Copyright Registrations. Executive agrees to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in any Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including, but not limited to, the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, declarations, assignments and all other instruments that the Company deems necessary in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Executive further agrees that Executive’s obligations

			
	9

to execute or cause to be executed, when it is in Executive’s power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of Executive’s mental or physical incapacity or for any other reason to secure Executive’s signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering any Inventions or original works of authorship assigned to the Company as above, then Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s agent and attorney in fact, to act for and in Executive’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by Executive.

(f)Exception to Assignments. Executive understands that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply to any Invention that Executive has developed entirely on Executive’s own time without using the Company’s equipment, supplies, facilities, trade secret information or Confidential Information (an “Other Invention”), except for those Other Inventions that either (i) relate in any way at the time of conception or reduction to practice of such Other Invention to the Company’s Business or
(ii) result from any work that Executive performed for the Company. Executive will advise the Company promptly in writing, under a confidentiality agreement, of any Invention that Executive believes constitutes an Other Invention and is not otherwise disclosed on Exhibit A. Executive agrees that Executive will not incorporate, or permit to be incorporated, any Other Invention owned by Executive or in which Executive has an interest into a Company product, process or service without the Company’s prior written consent. Notwithstanding the foregoing sentence, if, in the course of Executive’s employment with the Company, Executive incorporates into a Company product, process or service and Other Invention owned by Executive or in which Executive has an interest, Executive hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, transferable, sublicensable, worldwide license to reproduce, make derivative works of, distribute, perform, display, import, make, have made, modify, use, sell, offer to sell, and exploit in any other way such Other Invention as part of or in connection with such product, process or service, and to practice any method related thereto.

12.Disputes. Any dispute or controversy between the Company and Executive, arising out of or relating to this Agreement, the breach of this Agreement, the Company’s employment of Executive, or otherwise, shall be settled by binding arbitration conducted by and before a single arbitrator in San Mateo or San Francisco County, California administered by the American Arbitration Association in accordance with its Employment Arbitration Rules (the “AAA Rules”) then in effect and judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. Both Employee and the Company hereby waive the right to a trial by jury or judge, or by administrative proceeding, for any covered claim or dispute. To the extent the AAA Rules conflict with any provision or aspect of this Agreement, this Agreement shall control. The arbitrator shall have the authority to award any remedy or relief that a court of competent jurisdiction could order or grant, including, without limitation, the issuance of an injunction. However, either party may, without inconsistency with this arbitration provision, apply to any court having jurisdiction over such dispute or controversy and seek interim provisional, injunctive or other equitable relief until the arbitration award is rendered or the controversy is otherwise resolved. Except as necessary in court proceedings to enforce this arbitration provision or an award rendered hereunder, or to obtain interim relief, neither a party nor an arbitrator may disclose the

			
	10

existence, content or results of any arbitration hereunder without the prior written consent of the Company and Executive. All claims, disputes, or causes of action under this Agreement, whether by Employee or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity. The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. This Agreement is made under the provisions of the Federal Arbitration Act (9 U.S.C., Sections 1-14) (“FAA”) and will be construed and governed accordingly. It is the parties’ intention that both the procedural and the substantive provisions of the FAA shall apply. Questions of arbitrability (that is whether an issue is subject to arbitration under this agreement) shall be decided by the arbitrator. Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator. However, where a party already has initiated a judicial proceeding, a court may decide procedural questions that grow out of the dispute and bear on the final disposition of the matter. Each party shall bear its or her costs and expenses in any arbitration hereunder and one-half of the arbitrator’s fees and costs; provided, however, that the arbitrator shall have the discretion to award the prevailing party reimbursement of its or her reasonable attorney’s fees and costs, unless such award is prohibited by applicable law. Notwithstanding the foregoing, Executive and the Company shall each have the right to resolve any dispute or cause of action involving trade secrets, proprietary information, or intellectual property (including, without limitation, inventions assignment rights, and rights under patent, trademark, or copyright law) by court action instead of arbitration.

13.Notices. All notices given under this Agreement shall be in writing and shall be deemed to have been duly given (a) when delivered personally, (b) three business days after being mailed by first class certified mail, return receipt requested, postage prepaid, (c) one business day after being sent by a reputable overnight delivery service, postage or delivery charges prepaid, or (d) on the date on which a facsimile or e-mail is transmitted to the parties at their respective addresses. Any party may change its address for notice and the address to which copies must be sent by giving notice of the new addresses to the other party in accordance with this Section 13, except that any such change of address notice shall not be effective unless and until received.

If to the Company:

Cooley LLP
4401 Eastgate Mall San Diego, CA 92121
Attention:  

If to Executive, to Executive’s address on file with the Company

14.Tax Provisions.

(a)Section 409A. Notwithstanding anything in this Agreement to the contrary, the following provisions apply to the extent severance benefits provided herein are subject to the provisions of Section 409A of the Code and the regulations and other guidance thereunder and any

			
	11

state law of similar effect (collectively “Section 409A”). Severance benefits shall not commence until Executive’s Separation from Service. Each installment of severance benefits is a separate “payment” for purposes of Treasury Regulations Section 1.409A-2(b)(2)(i), and the severance benefits are intended to satisfy the exemptions from application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9). However, if such exemptions are not available and Executive is, upon Separation from Service, a “specified employee” for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal tax consequences under Section 409A, the timing of the severance benefits payments shall be delayed until the earlier of (i) six (6) months and one day after Executive’s Separation from Service, or (ii) Executive’ death. Executive shall receive severance benefits only if Executive executes and returns to the Company the Release within the applicable time period set forth therein and permits such Release to become effective in accordance with its terms, which date may not be later than sixty (60) days following the date of Executive’s Separation from Service (such latest permitted date, the “Release Deadline”). If the severance benefits are not covered by one or more exemptions from the application of Section 409A and the Release could become effective in the calendar year following the calendar year in which Executive’s Separation from Service occurs, the Release will not be deemed effective any earlier than the Release Deadline. None of the severance benefits will be paid or otherwise delivered prior to the effective date of the Release. Except to the minimum extent that payments must be delayed because Executive is a “specified employee” or until the effectiveness of the Release, all amounts will be paid as soon as practicable in accordance with the schedule provided herein and in accordance with the Company’s normal payroll practices. The severance benefits are intended to qualify for an exemption from application of Section 409A or comply with its requirements to the extent necessary to avoid adverse personal tax consequences under Section 409A, and any ambiguities herein shall be interpreted accordingly.

To the extent that any reimbursements payable to Executive under this Agreement are subject to the provisions of Section 409A: (i) to be eligible to obtain reimbursement for such expenses Executive must submit expense reports within forty-five (45) days after the expense is incurred,
(ii) any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, (iii) the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year, and (iv) the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

(b)Section 280G. If any payment or benefit Executive will or may receive from the Company or otherwise (a “280G Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment pursuant to this Agreement or otherwise (a “Payment”) shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the

			
	12

Reduced Amount is determined pursuant to clause (x) of the preceding sentence, the reduction shall occur in the manner (the “Reduction Method”) that results in the greatest economic benefit for Executive. If more than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the “Pro Rata Reduction Method”).

Notwithstanding the foregoing, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes pursuant to Section 409A, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as to avoid the imposition of taxes pursuant to Section 409A as follows: (A) as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic benefit for Executive as determined on an after-tax basis; (B) as a second priority, Payments that are contingent on future events (e.g., being terminated without cause), shall be reduced (or eliminated) before Payments that are not contingent on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning of Section 409A shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A.

Unless Executive and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general tax compliance purposes as of the day prior to the effective date of the change of control transaction triggering the Payment shall perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the change in control transaction, the Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to provide its calculations, together with detailed supporting documentation, to Executive and the Company within fifteen
(15) calendar days after the date on which Executive’s right to a 280G Payment becomes reasonably likely to occur (if requested at that time by Executive or the Company) or such other time as requested by Executive or the Company.

If Executive receives a Payment for which the Reduced Amount was determined pursuant to clause
(x) of the first paragraph of this Section 14(b) and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Executive shall promptly return to the Company a sufficient amount of the Payment (after reduction pursuant to clause (x) of the first paragraph of this Section 14(b) so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) in the first paragraph of this Section 14(b), Executive shall have no obligation to return any portion of the Payment pursuant to the preceding sentence.

15.Miscellaneous.

(a)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California without reference to principles of conflict of laws.

(b)Entire    Agreement/Amendments.    This    Agreement    and    the    instruments contemplated herein contain the entire understanding of the parties with respect to the employment

			
	13

of Executive by the Company from and after the Effective Date and supersede any prior agreements or promises between the Company and Executive, except for any outstanding stock option or other equity award agreement previously entered into between Executive and the Company. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other than those expressly set forth herein and therein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto.

(c)No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. Any such waiver must be in writing and signed by Executive or an authorized officer of the Company, as the case may be.

(d)Assignment. This Agreement shall be binding upon and inure to the benefit of the Company and Executive and their respective successors, assigns, executors and administrators. This Agreement shall not be assignable by Executive.

(e)Representation. Executive represents that Executive’s employment by the Company and the performance by Executive of her obligations under this Agreement do not, and shall not, breach any agreement, including, but not limited to, any agreement that obligates her to keep in confidence any trade secrets or confidential or proprietary information of her or of any other party, to write or consult to any other party or to refrain from competing, directly or indirectly, with the business of any other party. Executive shall not disclose to the Company or use any trade secrets or confidential or proprietary information of any other party.

(f)Successors; Binding Agreement; Third Party Beneficiaries. This Agreement shall inure to the benefit of and be binding upon the personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees legatees and permitted assignees of the parties hereto.

(g)Withholding Taxes. The Company shall withhold from any and all compensation, severance and other amounts payable under this Agreement such Federal, state, local or other taxes as may be required to be withheld pursuant to any applicable law or regulation.

(h)Survivorship. The respective rights and obligations of the parties hereunder, including without limitation Sections 8 through 11 hereof, shall survive any termination of Executive’s employment to the extent necessary to the agreed preservation of such rights and obligations.

(i)Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

(j)Headings. The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.
			
	14

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.

By: Bellicum Pharmaceuticals, Inc.

    /s/ Charity Scripture

Charity Scripture, MS, PharmD, BCOP

By: /s/ Rick Fair     Name: Rick Fair
Title: President and CEO

Signature Page to Agreement

EXHIBIT A INVENTIONSEX-10.2

 Exhibit 10.2 

Execution Version 

ESCROW AGREEMENT 
 This
ESCROW AGREEMENT, dated as of March 14, 2022 (together with Schedule A hereto, this “Agreement”), is by and among The Sinclair Companies, a Wyoming corporation, with principal offices located at 550 East South Temple, Salt Lake
City, Utah 84102 (“Sinclair HoldCo”); HF Sinclair Corporation (f/k/a Hippo Parent Corporation), a Delaware corporation, with principal offices located at 2828 North Harwood Street, Suite 1300, Dallas, Texas 75201 (“HFS”); and
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, a New York limited liability trust company, with principal offices located at 6201 15th Avenue, Brooklyn, New York, 11219 (“Escrow Agent”). 

WHEREAS, Sinclair HoldCo and HFS have entered into a Business Combination Agreement, dated August 2, 2021 (as amended to date, the
“BCA”), by and among HFS, HollyFrontier Corporation (“HollyFrontier”), Hippo Merger Sub, Inc., a wholly owned subsidiary of HFS (“Parent Merger Sub” and together with HollyFrontier and HFS, the “HFS Parties”),
Sinclair HoldCo, and Hippo Holding LLC, a wholly owned subsidiary of Sinclair HoldCo (the “Target Company”); 
 WHEREAS, Holly
Energy Partners, a Delaware limited Partnership (“HEP”), Sinclair HoldCo and Sinclair Transportation Company, a wholly owned subsidiary of Sinclair HoldCo (“STC”), have entered into a Contribution Agreement, dated August 2,
2021 (as amended to date the “Contribution Agreement”); 
 WHEREAS, pursuant to the BCA, HFS will acquire HollyFrontier and the
Target Company by effecting (a) a holding company merger in accordance with Section 251(g) of the Delaware General Corporation Law whereby Parent Merger Sub will merge with and into HollyFrontier, with HollyFrontier surviving such merger
as a direct wholly owned subsidiary of HFS (the “HFC Merger”), and (b) immediately following the HFC Merger, a contribution whereby Sinclair HoldCo will contribute all of the equity interests of the Target Company (and cash, if
applicable) to HFS in exchange for shares of HFS, resulting in the Target Company becoming a direct wholly owned subsidiary of HFS (together with the HFC Merger, the “HFC Transactions”); 

WHEREAS, pursuant to the Contribution Agreement HEP will acquire all of the outstanding shares of STC in exchange for 21 million newly
issued common units of HEP and cash consideration equal to $325 million (the “HEP Transaction” and together with the HFC Transactions, the “Sinclair Transactions”), subject to downward adjustment pursuant to the terms of the
Contribution Agreement; 
 WHEREAS, Section 2.5(e)(i) of the BCA provides that HFS shall deposit the Escrowed Securities (defined
below) with Escrow Agent, and the Escrow Agent shall place such Escrowed Securities in a segregated escrow account (the “Escrow Account”) titled in the name of Escrow Agent for the benefit of Sinclair HoldCo to be held by Escrow Agent in
accordance with this Agreement and the BCA for the purpose of securing Sinclair HoldCo’s obligations under Section 6.22 of the BCA; 

 WHEREAS, Section 3.2(b)(i) of the Contribution Agreement provides that HEP shall
deposit the Escrowed Securities with Escrow Agent, and the Escrow Agent shall place such Escrowed Securities in an Escrow Account titled in the name of Escrow Agent for the benefit of Sinclair HoldCo to be held by Escrow Agent in accordance with
this Agreement and the Contribution Agreement for the purpose of securing Sinclair HoldCo’s obligations under Section 6.22 of the BCA; 

WHEREAS, Escrow Agent has agreed to accept, hold, and disburse the Escrowed Securities deposited with it in accordance with the terms of this
Agreement, the BCA and the Contribution Agreement; 
 WHEREAS, pursuant to the BCA, Sinclair HoldCo and HFS have appointed the
Representatives (as defined below) to represent them for all purposes in connection with this Agreement (including the Escrowed Securities); and 

WHEREAS, in order to establish the Escrow Account and otherwise to effect the provisions of the BCA, the parties hereto have entered into this
Agreement. 
 NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto, for themselves, their successors and assigns, hereby agree as follows: 
  

	1.	 Definitions. The following terms shall have the meanings indicated or referred to below, inclusive of
their singular and plural forms, except where the context requires otherwise. Unless the context requires otherwise, all references to “years,” “months,” or “days” shall mean “calendar years,” “calendar
months,” and “calendar days.” References in this Agreement to “including” shall mean “including, without limitation,” whether or not so specified. Any term not defined below which is initially capitalized in this
Agreement shall have the meaning ascribed to it in this Agreement. 

 “Affiliate” means, with respect to any
person, (a) a person which directly or indirectly through one or more intermediaries controls, is controlled by or is under common control with such person, (b) any person of which such person is the beneficial owner of a twenty-five
percent (25%) or greater interest, or (c) any person which acquires all or substantially all of the assets of such person. A person is deemed to control another person if such person, directly or indirectly, has the power to direct the
management, operations or business of such person. The term “beneficial owner” is to be determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended. 

“Business Day” shall mean any day other than a Saturday, a Sunday, or a day on which banking institutions in the State of New York
are authorized or obligated by law or executive order to close. 
 “Escrowed Securities” shall have the meaning set forth in
Section 3(a). 
 “Escrow Period” shall mean the period commencing on the date hereof and ending on the
Termination Date. 

 “HFS Representative” shall mean the persons so designated on Schedule A
hereto or any other person designated in a writing signed by HFS and delivered to Escrow Agent and Sinclair HoldCo Representative in accordance with the notice provisions of this Agreement, to act as HFS’s representative under this Agreement.

 “Joint Written Direction” shall mean a joint written direction executed by the Representatives (as defined below) and directing
Escrow Agent to disburse all or a portion of the Escrowed Securities or to take or refrain from taking an action pursuant to this Agreement. 

“Representatives” shall mean Sinclair HoldCo Representative and HFS Representative. 

“Securities” shall mean the securities set forth on Schedule A hereto. 

“Sinclair HoldCo Representative” shall mean the person so designated on Schedule A hereto or any other person designated in a
writing signed by Sinclair HoldCo and delivered to Escrow Agent and HFS Representative in accordance with the notice provisions of this Agreement, to act as Sinclair HoldCo’s representative under this Agreement. 

 

	2.	 Appointment of and Acceptance by Escrow Agent. Sinclair HoldCo and HFS hereby appoint Escrow Agent to
serve as escrow agent hereunder. Escrow Agent hereby accepts such appointment and, upon receipt of the Escrowed Securities in accordance with Section 3 below, agrees to hold and disburse the Escrowed Securities in
accordance with this Agreement. 

  

	3.	 Deposit of Escrowed Securities. 

 

	 	(a)	 Simultaneously with the execution and delivery of this Agreement, HFS will deposit with the Escrow Agent the
Securities (as so deposited, together with any new, substitute or additional securities described in Section 3(c) below, the “Escrowed Securities”). 

 

	 	(b)	 Upon receipt of the Escrowed Securities, Escrow Agent shall deliver to the Representatives a written notice
confirming such receipt. 

  

	 	(c)	 If an issuer (the “Issuer”) of any Escrowed Securities declares or issues any dividend or other
distribution in respect of such Escrowed Securities which is payable in the form of shares of capital stock (or the equivalent) of such Issuer, or in the event of a stock split or other similar transaction pursuant to which such Issuer issues shares
of capital stock (or the equivalent) in respect of the shares (or units) represented by the Escrowed Securities and such distributed or issued shares (or units) are deposited with Escrow Agent, Escrow Agent shall deliver to the Representatives a
written notice confirming such deposit and Sinclair HoldCo and HFS shall promptly provide Escrow Agent with an update to Schedule A to reflect the deposit of such equity interests and such equity interests thereupon shall be deemed to be part
of the Escrowed Securities for purposes of this Agreement. 

	 	(d)	 All Escrowed Securities shall be held by Escrow Agent and disbursed only in accordance with Section 4
hereof, provided that the parties acknowledge that the Escrowed Securities shall be registered in the name of, and record owner thereof shall be, the party identified on Schedule A hereto, which shall initially be Sinclair HoldCo.

  

	 	(e)	 The Representatives shall sign a Joint Written Direction respecting any transfer or conversion of the
Securities. 

  

	 	(f)	 All cash dividends or distributions declared or paid in respect of the Escrowed Securities shall be paid
directly to the record owner thereof as identified on Schedule A hereto, which shall initially be Sinclair HoldCo, and shall not be held in escrow. 

  

	4.	 Disbursement of Escrowed Securities. 

 

	 	(a)	 Escrow Agent shall disburse the Escrowed Securities from time to time, upon receipt of, and in accordance with,
a Joint Written Direction. Such Joint Written Direction shall contain the account information to which the Escrowed Securities shall be transferred. Upon the expiration of the Escrow Period, Escrow Agent shall disburse, upon receipt of a Joint
Written Direction, the Escrowed Securities (or the remainder of such Escrowed Securities, after any disbursement in connection with any prior Joint Written Direction(s)) in the manner described on Schedule A. Any and all disbursement of the
Escrowed Securities under this Section 4 shall be made within five (5) Business Days of Escrow Agent’s receipt of a Joint Written Direction. 

 

	 	(b)	 If there is any amount of undisbursed or unclaimed Escrowed Securities on the Termination Date (as defined in
Schedule A hereto), and if Escrow Agent shall not have received a Joint Written Direction no later than five (5) days after the Termination Date, Escrow Agent, in addition to its other rights herein, (x) (A) may maintain and manage
such Escrowed Securities for such period of time as it determines may be necessary or appropriate, including in accordance with applicable state escheatment and unclaimed property laws, as determined by Escrow Agent in its sole discretion and
(B) shall have the right to escheat any such Escrowed Securities pursuant to applicable state escheatment and unclaimed property laws and, in such case, shall remit such Escrowed Securities (less any fees, costs, expenses or other amounts due
to Escrow Agent or any other Indemnified Party (as defined below) in accordance with this Agreement (including Schedule A hereto)) to any relevant competent authority and (y) may take any other action permitted by this Agreement,
including Section 6, Section 7 and Section 10 of this Agreement. 

	5.	 Voting Rights. The record owners of the Escrowed Securities as identified on Schedule A
hereto, which shall initially be Sinclair HoldCo, shall be entitled to exercise any and all voting and other consensual rights with respect to such shares during such period as they are held in escrow without restriction hereunder.

  

	6.	 Suspension of Performance. If, at any time, (i) there shall exist any dispute between or among
Sinclair HoldCo, HFS and/or either of the Representatives with respect to the holding or disposition of all or any portion of the Escrowed Securities or any other obligations of Escrow Agent hereunder, (ii) Escrow Agent is unable to determine,
to Escrow Agent’s sole satisfaction, the proper disposition of all or any portion of the Escrowed Securities or Escrow Agent’s proper actions with respect to its obligations hereunder, or (iii) the Representatives have not, within
thirty (30) days of the furnishing by Escrow Agent of a notice of resignation pursuant to Section 7 hereof, appointed a successor escrow agent to act hereunder (which such successor escrow agent has accepted such
appointment), then Escrow Agent may, in its reasonable discretion, suspend the performance of any of its obligations (including any disbursement obligations) under this Agreement until such dispute or uncertainty shall be resolved to the sole
satisfaction of Escrow Agent or until a successor escrow agent shall have been appointed (as the case may be). 

 Escrow
Agent shall have no liability to Sinclair HoldCo, HFS, or either of the Representatives, or to their respective shareholders, partners, or members, officers or directors, employees, Affiliates or any other person with respect to any such suspension
of performance, specifically including any liability or claimed liability that may arise, or be alleged to have arisen, out of or as a result of any delay in the disbursement of Escrowed Securities or any delay in or with respect to any other action
required or requested of Escrow Agent, absent willful misconduct, fraud or gross negligence by the Escrow Agent. 
  

	7.	 Resignation of Escrow Agent. Escrow Agent may resign and be discharged from the performance of its
duties hereunder at any time by giving thirty (30) days’ prior written notice to Sinclair HoldCo, HFS, and the Representatives specifying the date when such resignation shall take effect. Upon any such notice of resignation, the
Representatives shall jointly issue to Escrow Agent a Joint Written Direction authorizing redelivery of the Escrowed Securities to a bank or trust company that has been retained as successor to Escrow Agent hereunder prior to the effective date of
such resignation. The retiring Escrow Agent shall transmit all records pertaining to the Escrowed Securities and shall transfer all Escrowed Securities to the successor escrow agent, after making copies of such records as the retiring Escrow Agent
deems advisable and after payment to the retiring Escrow Agent of all reasonable and documented fees, costs and out-of-pocket expenses (including court costs and
expenses and reasonable outside attorneys’ fees) or any other amount payable to or incurred by the retiring Escrow Agent in connection with the performance of its duties and the exercise of its rights hereunder. 

After any retiring Escrow Agent’s resignation, the provisions of this Agreement shall inure to its benefit as to any actions taken or
omitted to be taken by it while it was Escrow Agent under this Agreement. Any corporation or other entity into which Escrow Agent may be merged or converted or with which it may be merged or consolidated, or any other entity to which all or a
majority of all of Escrow Agent’s escrow business may be transferred by sale of assets or otherwise, shall be Escrow Agent under this Agreement without further act or consent of any party hereto. 

	8.	 Liability of Escrow Agent. Escrow Agent undertakes to perform only the ministerial duties as are
expressly set forth herein and no other duties and obligations (fiduciary or otherwise) shall be implied. Escrow Agent shall have no duty to enforce any obligation of any other person to make any payment or delivery, or to direct or cause any
payment or delivery to be made, or to enforce any obligation of any other person to perform any other act. Escrow Agent shall have no liability under and no duty to inquire as to the provisions of any agreement (even though such agreement may be
referenced in this Agreement) other than this Agreement. In the event of any conflict between the terms and provisions of this Agreement and any other agreement, as to Escrow Agent, the terms and conditions of this Agreement shall control subject to
Section 29 hereof. Escrow Agent is not a party to the BCA, is not bound by any of its terms, and has not undertaken in any way to effectuate, implement or comply with the BCA. Escrow Agent shall not be liable to Sinclair
HoldCo or HFS or to anyone else for any action taken or omitted by it in good faith except to the extent that a court of competent jurisdiction determines that Escrow Agent’s fraud, gross negligence or willful misconduct was the primary cause
of any loss to Sinclair HoldCo or HFS. Escrow Agent’s sole responsibility shall be for the safekeeping and disbursement of the Escrowed Securities in accordance with the terms of this Agreement. Escrow Agent shall have no implied duties or
obligations and shall not be charged with knowledge or notice of any fact or circumstance not specifically set forth herein. Escrow Agent shall have no duty to solicit any payment which may be due to be paid with respect to the Escrowed Securities
or to confirm or verify the accuracy or correctness of any Escrowed Securities deposited in accordance with this Agreement. Escrow Agent may rely conclusively, and shall be protected in acting, upon any notice, instruction (including a Joint Written
Direction (such as a wire transfer instruction)), request, order, judgment, certification, opinion or advice of counsel (including counsel chosen by Escrow Agent), statement, demand or other instrument or document, not only as to its due execution,
validity (including the authority of the person signing or presenting the same) and effectiveness, but also as to the truth and accuracy of any information contained therein, which Escrow Agent shall believe to be genuine and to have been signed or
presented by the person or parties purporting to sign the same. In no event shall Escrow Agent be liable for incidental, indirect, special, consequential or punitive damages of any kind whatsoever (including lost profits), even if Escrow Agent has
been advised of the likelihood of such loss or damage and regardless of the form of action, absent gross negligence, fraud or willful misconduct by Escrow Agent. The officers, directors, members, partners, trustees, employees, agents, attorneys or
other representatives and Affiliates of Escrow Agent owe no duty or obligation to any party hereunder and shall have no liability to any person by reason of any error of judgment, for any act done or not done, for any mistake of fact or law, or
otherwise, absent gross negligence, fraud or willful misconduct. 

 Escrow Agent shall not be obligated to take any legal or other action or commence any
proceeding in connection with the Escrowed Securities, the Escrow Account or any other account in which the Escrowed Securities are deposited, this Agreement or the BCA, or to appear in, prosecute or defend any such legal action or proceeding
(whether or not it shall have been furnished with acceptable indemnification and advancement). Escrow Agent may consult legal counsel selected by it in the event of any dispute or question as to the construction of any of the provisions hereof or of
any other agreement or of its duties hereunder, or relating to any dispute or question involving any party hereto, and shall incur no liability and shall be fully indemnified from any liability whatsoever in acting in accordance with the opinion or
instruction of such counsel. Sinclair HoldCo and HFS, jointly and severally, shall promptly pay, upon demand, the reasonable fees, costs and expenses of any such counsel. Escrow Agent shall have no responsibility with respect to the use or
application of any Escrowed Securities disbursed by Escrow Agent pursuant to the provisions hereof. 
 Escrow Agent is authorized, in its
sole discretion, to comply with orders issued or process entered by any court with respect to the Escrowed Securities, without determination by Escrow Agent of such court’s jurisdiction in the matter. If any portion of the Escrowed Securities
is at any time attached, garnished or levied upon under any court order, or in case the payment, assignment, transfer, conveyance or delivery of any such property shall be stayed or enjoined by any court order, or in case any order, judgment or
decree shall be made or entered by any court affecting such property or any part thereof, then and in any such event, Escrow Agent is authorized, in its sole discretion, to rely upon and comply with any such order, writ, judgment or decree which it
is advised by outside legal counsel selected by it is binding upon it without the need for appeal or other action; and if Escrow Agent complies with any such order, writ, judgment or decree, it shall not be liable to any of the parties hereto or to
any other person or entity by reason of such compliance even though such order, writ, judgment or decree may be subsequently reversed, modified, annulled, set aside or vacated. 

 

	9.	 Indemnification of Escrow Agent. From and at all times after the date of this Agreement, Sinclair HoldCo
and HFS, jointly and severally, shall, to the fullest extent permitted by law, defend, indemnify and hold harmless Escrow Agent and each director, officer, member, partner, trustee, employee, attorney, agent and Affiliate of Escrow Agent
(collectively, the “Indemnified Parties”) against any and all actions, claims (whether or not valid), losses, damages, liabilities, costs, penalties, settlements, judgments and expenses of any kind or nature whatsoever (including costs and
expenses and reasonable attorneys’ fees) incurred by or asserted against any of the Indemnified Parties from and after the date hereof, whether direct, indirect or consequential, as a result of, in connection with, or arising from or in any way
relating to any claim, demand, suit, action or proceeding (including any inquiry or investigation) by any person, including Sinclair HoldCo, HFS and/or the Representatives, whether threatened or initiated, asserting a claim for any legal or
equitable remedy against any person (whether it is an Indemnified Party or not) under any statute or regulation, including any federal or state securities laws, or under any common law or equitable cause or otherwise, arising from or in connection
with the negotiation, preparation, execution, performance or failure of performance of this Agreement or any transactions contemplated herein or relating hereto (including tax reporting or withholding or the enforcement of any rights or remedies
under or in connection with this Agreement), whether or not any such Indemnified Party 

	 	
is a party to any such action, proceeding, suit or the target of any such inquiry or investigation (without derogation of any other indemnity afforded to Escrow Agent); provided, however,
that no Indemnified Party shall have the right to be indemnified hereunder for any liability finally determined by a court of competent jurisdiction, subject to no further appeal, to have resulted from the fraud, gross negligence or willful
misconduct of such Indemnified Party. Each Indemnified Party shall, in its sole discretion, have the right to select and employ separate counsel with respect to any action or claim brought or asserted against it, and the reasonable fees of such
counsel (and such counsel’s costs and expenses) shall be paid, upon demand, by Sinclair HoldCo and HFS jointly and severally. 

The parties hereto agree that neither the payment by Sinclair HoldCo or HFS of any claim by Escrow Agent for indemnification hereunder nor the
disbursement of any amounts to Escrow Agent from the Escrow Account in respect of a claim by Escrow Agent for indemnification shall impair, limit, modify, or affect, as between Sinclair HoldCo and HFS, the respective rights and obligations of
Sinclair HoldCo, on the one hand, and HFS, on the other hand, under the BCA. 
  

	10.	 Fees, Costs and Expenses of Escrow Agent. Sinclair HoldCo and HFS shall compensate Escrow Agent for its
services hereunder in accordance with Schedule A attached hereto and, in addition, shall reimburse Escrow Agent for all of its reasonable and documented
out-of-pocket costs and expenses, including outside attorneys’ fees, travel expenses, telephone and facsimile transmission costs, postage (including express mail
and overnight delivery charges), copying charges and the like. The additional provisions and information set forth on Schedule A hereto are hereby incorporated by this reference, and form a part of this Agreement. All of the compensation and
reimbursement obligations set forth in this Section 10 shall be payable by Sinclair HoldCo and HFS, jointly and severally, upon execution of this Agreement and, in the future, upon demand by Escrow Agent; provided, that HFS
and Sinclair HoldCo hereby agree between themselves to each pay 50% of any such compensation, fees or other amounts due hereunder to Escrow Agent. 

  

	11.	 Representations and Warranties. Each of Sinclair HoldCo and HFS severally covenants and makes the
following representations and warranties to Escrow Agent: 

  

	 	(a)	 It is duly organized, validly existing, and in good standing under the laws of the state of its incorporation
or organization, and has full power and authority to execute and deliver this Agreement and to perform its obligations hereunder. 

  

	 	(b)	 It possesses such valid and current licenses, certificates, authorizations or permits issued by the appropriate
state, federal or foreign regulatory agencies or bodies necessary to conduct its respective businesses, and it has not received any notice of proceedings relating to the revocation or modification of, or
non-compliance with, any such license, certificate, authorization or permit. 

  

	 	(c)	 This Agreement has been duly approved by all necessary action, including any necessary shareholder or
membership approval, has been executed by its duly authorized officers, and constitutes its valid and binding agreement enforceable in accordance with its terms. 

	 	(d)	 The execution, delivery, and performance of this Agreement is in accordance with the BCA and will not violate,
conflict with, or cause a default under its articles of incorporation, bylaws, management agreement or other organizational document, as applicable, any applicable law, rule or regulation, any court order or administrative ruling or decree to which
it is a party or any of its property is subject, or any agreement, contract, indenture, or other binding arrangement, including the BCA, to which it is a party or any of its property is subject. 

 

	 	(e)	 The applicable persons designated on Schedule A hereto have been duly appointed to act as its
representatives hereunder and have full power and authority to execute and deliver any Joint Written Direction, to amend, modify or waive any provision of this Agreement and to take any and all other actions as the Representatives under this
Agreement, all without further consent or direction from, or notice to, it or any other party. 

  

	 	(f)	 No party other than the parties hereto has, or shall have, any lien, claim or security interest in the Escrowed
Securities or any part thereof. No financing statement under the Uniform Commercial Code is on file in any jurisdiction claiming a security interest in or describing (whether specifically or generally) the Escrowed Securities or any part thereof.

  

	 	(g)	 All of its representations and warranties contained herein are true and complete as of the date hereof and will
be true and complete at the time of any disbursement of the Escrowed Securities. 

  

	12.	 Patriot Act Disclosure; Taxpayer Certification and Reporting. 

 

	 	(a)	 Patriot Act Disclosure. Sinclair HoldCo and HFS acknowledge that a portion of the identifying
information set forth on Schedule A hereto is being requested by Escrow Agent in connection with the USA Patriot Act, Pub.L.107-56 (the “Act”), and Sinclair HoldCo and HFS agree to provide any
additional information requested by Escrow Agent in connection with the Act or any similar law, rule, regulation, order, or other governmental act to which Escrow Agent is subject, in a timely manner and consent to Escrow Agent obtaining from third
parties any such identifying information. Sinclair HoldCo and HFS each represent that all identifying information set forth on Schedule A hereto, including its Taxpayer Identification Number assigned by the Internal Revenue Service or any
other taxing authority, is true and complete on the date hereof and will be true and complete at the time of any disbursement of the Escrowed Securities. For a non-individual person such as a charity, a trust,
or other legal entity, Escrow Agent may require documentation to verify formation and existence as a legal entity. Escrow Agent may also require financial statements, licenses, identification and authorization documentation from any individual
claiming authority to represent the entity or other relevant documentation. 

	 	(b)	 Certification and Tax Reporting. Each of Sinclair HoldCo and HFS has provided Escrow Agent with its
respective fully executed Internal Revenue Service (“IRS”) Form W-9 and/or other required tax documentation. Each of Sinclair HoldCo and HFS acknowledges that, solely for U.S. federal (and where
applicable, state and local) income tax purposes, (i) Escrow Agent does not have any interest in the Escrowed Securities or the Escrow Account, and (ii) the Escrowed Securities shall be the property of (and owned by) the record owner
thereof, as identified on Schedule A hereto, which shall initially be Sinclair HoldCo. Escrow Agent shall not have any liability for the payment of taxes with respect to the Escrowed Securities, and Sinclair HoldCo shall indemnify and hold
Escrow Agent harmless from and against all such taxes. Escrow Agent shall withhold any taxes it deems appropriate in the absence of proper tax documentation or as required by law and shall remit such taxes to the appropriate authorities. Each of
Sinclair HoldCo and HFS hereby represents and warrants to Escrow Agent that (i) by providing an IRS From W-9 each such person is certifying as to its non-foreign
status for purposes of Section 1445 and Section 1446 of the Internal Revenue Code of 1986, as amended, and (ii) such underlying transaction does not constitute an installment sale requiring any tax reporting or withholding of imputed
interest or original issue discount, in each case by the Escrow Agent to the IRS or other taxing authority. 

  

	13.	 Consent to Jurisdiction and Venue. In the event that any party hereto commences a lawsuit or other
proceeding relating to or arising from this Agreement, the parties hereto agree that the United States District Court for the Southern District of the State of New York shall have the sole and exclusive jurisdiction over any such proceeding. If such
court lacks federal subject matter jurisdiction, the parties hereto agree that the Supreme Court of the State of New York within New York County shall have sole and exclusive jurisdiction. Any final judgment shall be conclusive and may be enforced
in other jurisdictions by suit on the judgment or in any other manner provided by law. Any of these courts shall be proper venue for any such lawsuit or judicial proceeding and the parties hereto waive any objection to such venue and irrevocably and
unconditionally waive and agree not to plead or claim in any such court that any such suit or proceeding in any such court has been brought in an inconvenient forum. 

The parties hereto consent to and agree to submit to the jurisdiction of any of the courts specified herein and agree to accept service of
process to vest personal jurisdiction over them in any of these courts. 
 Each party hereto irrevocably and unconditionally waives any right
to a trial by jury and agrees that any of them may file a copy of this section of this Agreement with any court as written evidence of the knowing, voluntary and bargained-for agreement among the parties
hereto irrevocably to waive the right to trial by jury in any litigation related to or arising under this Agreement. 

	14.	 Notice. All notices, instructions (pursuant to a Joint Written Direction or otherwise), approvals,
consents, requests, and other communications hereunder shall be in writing and shall be deemed to have been given (a) when such writing is delivered by hand or overnight delivery service, or (b) upon telephone call-back in accordance with
Section 15 below, after being sent by e-mail with PDF attachment from the designated e-mail account(s) of the sending person(s) as designated
on Schedule A hereto to the designated e-mail account(s) of the receiving person(s) as designated on Schedule A hereto or (c) three (3) Business Days after being mailed by first class mail
(postage prepaid), in each case to the address set forth on Schedule A hereto or to such other address as each party hereto may designate for itself by like notice. 

 

	15.	 Security Procedures. If notices, instructions (pursuant to a Joint Written Direction or otherwise),
approvals, consents, requests, and other communications, are received by Escrow Agent by e-mail at its e-mail account(s) as designated on Schedule A hereto,
Escrow Agent is authorized, but not required, to seek prompt confirmation of such communications by telephone call-back to the sending person or persons’ telephone number(s) as designated on Schedule A hereto, and Escrow Agent may rely
upon the confirmation of anyone purporting to be the person or persons so designated in that call-back. Any e-mail by PDF attachment executed by more than one person shall be sent by each signatory. The
persons and their telephone numbers authorized to receive call-backs as designated in Schedule A hereto may be changed only in a writing actually received and acknowledged by Escrow Agent and delivered in accordance with
Section 14 above and, if applicable, this Section 15. If Escrow Agent is unable to contact any such designated person, Escrow Agent is hereby authorized (but not required) both to receive written
instructions from and seek confirmation of such instructions by telephone call-back to any one or more of Sinclair HoldCo’s or HFS’s officers (each, an “Officer”), as the case may be, who shall include individuals holding titles
of Treasurer or Chief Financial Officer or more senior thereto, as Escrow Agent may select. Such Officer(s) shall deliver to Escrow Agent a fully executed incumbency certificate upon Escrow Agent’s request, and Escrow Agent may rely upon the
confirmation of anyone purporting to be any such Officer(s). The parties to this Agreement acknowledge and agree that the security procedures set forth above are commercially reasonable. 

 

	16.	 Amendment or Waiver. This Agreement may be changed, waived, discharged or terminated only by a writing
signed by the parties hereto. No delay or omission by any party hereto in exercising any right with respect hereto shall operate as a waiver. A waiver on any one occasion shall not be construed as a bar to, or waiver of, any right or remedy on any
future occasion. 

  

	17.	 Severability. To the extent any provision of this Agreement is prohibited by or invalid under applicable
law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

 

	18.	 Governing Law. This Agreement shall be construed and interpreted in accordance with the internal laws of
the State of New York without giving effect to the conflict of laws principles thereof. 

  

	19.	 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto relating to
the holding, investment and disbursement of Escrowed Securities and sets forth in their entirety the obligations and duties of Escrow Agent with respect to the Escrowed Securities. 

	20.	 Binding Effect. All of the terms of this Agreement, as amended from time to time, shall be binding upon,
inure to the benefit of and be enforceable by the respective successors and assigns of Sinclair HoldCo, HFS and Escrow Agent. 

  

	21.	 Execution in Counterparts. This Agreement and any Joint Written Direction may be executed in two or more
counterparts, which when so executed shall constitute one and the same agreement or direction. Subject to Section 14 and Section 15 hereof, this Agreement and any Joint Written Direction may be
executed and delivered by e-mailing a PDF version of a signed signature page, which shall have the same force and effect as the delivery of an originally executed signature page. 

 

	22.	 Termination of Escrow Agent. Upon the first to occur of (i) the termination of the Escrow Period
(and the occurrence of the related distribution(s)), (ii) the disbursement of all Escrowed Securities pursuant to one or more Joint Written Directions, into court pursuant to Section 6 hereof, in accordance with applicable
state escheatment and unclaimed property laws or otherwise or (iii) the resignation of Escrow Agent, Escrow Agent shall be released from its obligations hereunder and Escrow Agent shall have no further obligation or liability whatsoever with
respect to this Agreement or the Escrowed Securities. The obligations of Sinclair HoldCo and HFS continue to exist notwithstanding the termination or discharge of Escrow Agent’s obligations or liabilities hereunder until the obligations of
Sinclair HoldCo and HFS have been fully performed. 

  

	23.	 Dealings. Escrow Agent and any stockholder, director, officer or employee of Escrow Agent may buy, sell,
and deal in any of the securities of Sinclair HoldCo or HFS and become pecuniarily interested in any transaction in which Sinclair HoldCo or HFS may be interested, and contract and lend money to Sinclair HoldCo or HFS and otherwise act as fully and
freely as though it were not Escrow Agent under this Agreement. Nothing herein shall preclude Escrow Agent from acting in any other capacity for Sinclair HoldCo or HFS or for any other entity. 

 

	24.	 Currency. The currency applicable to any amount payable or receivable under this Agreement is United
States dollars. 

  

	25.	 Force Majeure. Notwithstanding anything to the contrary hereunder, Escrow Agent shall not be liable for
any delay, failure to perform, or other act or non-act resulting from acts beyond its reasonable control, including acts of God, terrorism, shortage of supply, labor difficulties (including strikes), war,
civil unrest, fire, floods, electrical outages, equipment or transmission failures, internet interruption, vendor failures (including information technology providers), and other similar causes. 

 

	26.	 No Third Party Beneficiaries. This Agreement and all of its terms and conditions are for the sole and
exclusive benefit of the parties hereto and their respective permitted successors and assigns. Nothing expressed or referred to in this Agreement will be construed to give any person or entity other than the parties to this Agreement any legal or
equitable rights, remedy, or claim under or with respect to this Agreement or any term or condition of this Agreement. 

	27.	 No Strict Construction. The parties hereto have participated jointly in the negotiation and draft of
this Agreement. In the event any ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if it were drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or
disfavoring any party hereto by virtue of authorship of any provision of this Agreement. 

  

	28.	 Priority. 

  

	 	(a)	 In the event of any conflict between the provisions of Schedule A hereto and the remainder of this
Agreement, this Agreement shall be construed in a manner prescribed by Escrow Agent acting in good faith. 

  

	 	(b)	 Nothing contained in this Agreement shall amend, replace or supersede any agreement between Sinclair HoldCo or
HFS and Escrow Agent to act as Sinclair HoldCo’s or HFS’s transfer agent, which agreement shall remain of full force and effect. 

  

	29.	 Headings. The headings in this Agreement are for convenience purposes and shall be ignored for purposes
of enforcing this Agreement, do not constitute a part of this Agreement, and may not be used by any party hereto to characterize, interpret, limit or affect otherwise any provision of this Agreement. 

[signature page follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the
date first above written. 
  

			
	THE SINCLAIR COMPANIES
		
	By:	 	/s/ Ross B. Matthews
		 	Name: Ross B. Matthews
		 	Title: Chief Operating Officer
	
	HF SINCLAIR CORPORATION
		
	By:	 	/s/ Michael Jennings
		 	Name: Michael Jennings
		 	Title: Chief Executive Officer
	
	AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Escrow Agent
		
	By:	 	/s/ Michael Legregin
		 	Name: Michael Legregin
		 	Title: Senior Vice President, Attorney Advisory Group

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]